%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
2013-10-23T20:45:14+03:00
2013-10-23T20:45:14+03:00
2013-10-23T20:45:14+03:00
application/pdf
bs-0468R-Biotin
uuid:b07bc56e-d899-4d2f-a8d7-7a89ae8abd4c
uuid:71ca373f-d319-4d0e-8f9f-91a43514e156
Acrobat Web Capture 9.0
endstream
endobj
5 0 obj
<>
endobj
6 0 obj
<>
endobj
3 0 obj
<>
endobj
7 0 obj
<>
endobj
11 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC/ImageI]/XObject<>>>/Type/Page>>
endobj
12 0 obj
[32 0 R]
endobj
13 0 obj
<>stream
/CS0 cs 1 scn
10 815.726 574.5 -735.891 re
f
BT
0.2 scn
/TT0 1 Tf
6.6416 0 0 6.6416 21.2908 767.2422 Tm
(www.biossusa.com)Tj
0 -1.5 TD
(support@biossusa.com)Tj
-0.012 Tw 0 -1.5 TD
[(800.501.7654)-34( )1([DOMESTIC])]TJ
0 -1.5 TD
[(+1.781.569.5821)-57( )1([INTERNATIONAL])]TJ
ET
q
/GS0 gs
141.4664764 0 0 -79.6994171 438.3843994 810.412735 cm
/Im0 Do
Q
BT
0 scn
/TT1 1 Tf
0 Tw 9.2983 0 0 9.2983 21.2908 715.4376 Tm
[(bs)-67(-)-69(0468R)-12(-)-69(Biotin)]TJ
/TT0 1 Tf
-0.04 Tw 7.3058 0 0 7.3058 28.5965 668.9462 Tm
[(Conjugated)-58( Primary)-1( Antibodies)]TJ
/TT1 1 Tf
0 Tw 0 -2.091 TD
(Background:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[([FUNCTION]Induces)-73( susceptibility)-11( to)-32( atherosclerosis)-13( \(By)-75( similarity\).)-31( Cell)-51( adhesion)-62( molecule)-88( which)-88( is)-52( required)-62( for)]TJ
0 -1.455 TD
[(leukocyte)-9( transendothelial)-58( migration)-11( \(TEM\))-45( under)-81( most)-19( inflammatory)-19( conditions.)-61( Tyr)-12(-)-1(690)-89( plays)-22( a)-20( critical)-81( role)-69( in)]TJ
0 -1.455 TD
[(TEM)-84( and is)-52( required)-62( for)-52( efficient)-46( trafficking)-71( of)-48( PECAM1)-6( to)-32( and from)-30( the)-36( lateral)-90( border)-14( recycling)-34( compartment)]TJ
0 -1.455 TD
[(\(LBRC\))-16( and is)-52( also)-75( essential)-90( for)-52( the)-36( LBRC)-55( membrane)-90( to)-32( be)-12( targeted)-16( around)-85( migrating)-1( leukocytes.)-78( Prevents)]TJ
T*
[(phagocyte)-85( ingestion)-24( of)-48( closely)-68( apposed)-28( viable)-76( cells)-18( by)-40( transmitting)-64( 'detachment')-90( signals,)-75( and changes)-9( function)]TJ
0 -1.455 TD
[(on)-81( apoptosis,)-70( promoting)-32( tethering)-22( of)-48( dying)-63( cells)-18( to)-32( phagocytes)-3( \(the)-17( encounter)-31( of)-48( a)-20( viable)-76( cell)-10( with)-46( a)-20( phagocyte)]TJ
0 -1.455 TD
[(via)-21( the)-37( homophilic)-75( interaction)-70( of)-48( PECAM1)-6( on)-81( both)-12( cell)-10( surfaces)-87( leads)-85( to)-32( the)-36( viable)-76( cell's)-80( active)-63( repulsion)-89( from)-30( the)]TJ
0 -1.455 TD
[(phagocyte.)-55( During)-64( apoptosis,)-70( the)-36( inside)-4(-)-1(out)-19( signaling)-29( of)-48( PECAM1)-6( is)-52( somehow)-75( disabled)-22( so)-11( that)-67( the)-37( apoptotic)-16( cell)]TJ
0 -1.455 TD
[(does)-23( not)-20( actively)-64( reject)-56( the)-37( phagocyte)-85( anymore.)-29( The)-59( lack)-14( of)-48( this)-69( repulsion)-89( signal)-5( together)-84( with)-46( the)-36( interaction)-70( of)]TJ
T*
[(the)-36( eat)-69(-)-1(me)-89( signals)-14( and their)-84( respective)-86( receptors)-73( causes)-38( the)-36( attachment)-5( of)-48( the)-36( apoptotic)-16( cell)-10( to)-32( the)-37( phagocyte,)]TJ
0 -1.455 TD
[(thus)-13( triggering)-18( the)-36( process)-29( of)-48( engulfment\).)-41( Isoform)-31( Delta15)-71( is)-52( unable)-51( to)-32( protect)-71( against)-12( apoptosis.)-70( Modulates)]TJ
0 -1.455 TD
[(BDKRB2)-25( activation.)-6( Regulates)-46( bradykinin)-75(-)-1( and hyperosmotic)-18( shock)-39(-)-1(induced)-16( ERK1/2)-29( activation)-37( in)-31( human)-52( umbilical)]TJ
T*
[(cord)-83( vein)-7( cells)-18( \(HUVEC\).)]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Purification:)Tj
/TT0 1 Tf
-0.04 Tw 6.727 -0.091 Td
[(Was)-36( purified)-38( by)-40( Protein)-81( A)-36( and peptide)-90( affinity)-82( chromatography.)]TJ
/TT1 1 Tf
0 Tw -6.727 -2 Td
(Storage:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(Aqueous)-34( buffered)-15( solution)-14( containing)-88( 100ug/ml)-73( BSA,)-42( 50%)-22( glycerol)-56( and less)-80( than)-25( 0.09%)-82( sodium)-13( azide.)-56( Store)-44( at)-50( -)]TJ
T*
[(20\260C)-18( for)-52( 12)-90( months.)-54( [Product)-75( without)-66( BSA)-72( and/or)-79( sodium)-13( azide)-87( is)-52( available)-70( for)-52( special)-31( order.])]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Reconstitution:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(If)-36( the)-36( antibody)-25( is)-52( in)-31( liquid)-13( form,)-91( no)-81( reconstitution)-78( needed.)]TJ
0 -2.909 TD
[(Reconstitution)-90( is)-52( only)-81( required)-62( for)-52( the)-36( lyophilized)-45( antibody.)-86( Please)-15( refer)-92( to)-32( the)-37( reconstitution)-78( instruction)-26( card)-10( in)]TJ
0 -1.455 TD
[(the)-36( package.)]TJ
/TT1 1 Tf
0 Tw 54.182 38.545 Td
(Size:)Tj
/TT0 1 Tf
3 -0.091 Td
(100ul)Tj
/TT1 1 Tf
-3 -2.818 Td
(Concentration:)Tj
/TT0 1 Tf
8.091 -0.091 Td
(1ug/uL)Tj
/TT1 1 Tf
-8.091 -2.818 Td
(Host:)Tj
/TT0 1 Tf
3.273 -0.091 Td
(Rabbit)Tj
/TT1 1 Tf
-3.273 -1.909 Td
(Reactivities:)Tj
0.2 scn
/TT0 1 Tf
6.6416 0 0 6.6416 482.2191 633.0815 Tm
(Human,Mouse,Rat,Dog,)Tj
0 scn
/TT1 1 Tf
7.3058 0 0 7.3058 424.437 619.1341 Tm
(Application:)Tj
ET
q
10 36 575 780 re
W n
q 1 0 0 1 434.3994 601.5338 cm
0 0 m
0 1.328 -1.992 1.328 -1.992 0 c
-1.992 -1.328 0 -1.328 0 0 c
f
Q
Q
BT
/TT0 1 Tf
7.3058 0 0 7.3058 441.041 599.8734 Tm
[(WB\(1:100)-42(-)-1(500\))]TJ
ET
q
10 36 575 780 re
W n
q 1 0 0 1 434.3994 590.9072 cm
0 0 m
0 1.328 -1.992 1.328 -1.992 0 c
-1.992 -1.328 0 -1.328 0 0 c
f
Q
Q
BT
/TT0 1 Tf
7.3058 0 0 7.3058 441.041 589.2468 Tm
[(ELISA\(1:500)-35(-)-1(1000\))]TJ
ET
q
10 36 575 780 re
W n
q 1 0 0 1 434.3994 580.2806 cm
0 0 m
0 1.328 -1.992 1.328 -1.992 0 c
-1.992 -1.328 0 -1.328 0 0 c
f
Q
Q
BT
/TT0 1 Tf
7.3058 0 0 7.3058 441.041 578.6202 Tm
[(IHC)-78(-)-1(P\(1:100)-73(-)-1(500\))]TJ
ET
q
10 36 575 780 re
W n
q 1 0 0 1 434.3994 569.6541 cm
0 0 m
0 1.328 -1.992 1.328 -1.992 0 c
-1.992 -1.328 0 -1.328 0 0 c
f
Q
Q
BT
/TT0 1 Tf
-0.04 Tw 7.3058 0 0 7.3058 441.041 567.9937 Tm
[(Not)-1( yet)-6( tested)-8( in)-31( other)-43( applications.)]TJ
T*
[(Optimal)-36( working)-62( dilutions)-48( must)-4( be)]TJ
0 -1.455 TD
[(determined)-86( by)-40( the)-36( end)-90( user.)]TJ
/TT1 1 Tf
-0.02 Tw -2.273 -3.818 Td
[(Antibody)-48( Type:)]TJ
/TT0 1 Tf
0 Tw 8.182 -0.091 Td
(Polyclonal)Tj
/TT1 1 Tf
-8.182 -1.909 Td
(Isotype:)Tj
0.2 scn
/TT0 1 Tf
6.6416 0 0 6.6416 467.6075 504.2341 Tm
(IgG)Tj
0 scn
/TT1 1 Tf
-0.02 Tw 7.3058 0 0 7.3058 424.437 490.2867 Tm
[(Molecular)-1( Weight:)]TJ
0.2 scn
/TT0 1 Tf
0 Tw 6.6416 0 0 6.6416 503.4723 490.2867 Tm
(78kDa)Tj
0 scn
/TT1 1 Tf
7.3058 0 0 7.3058 424.437 476.3393 Tm
(Note:)Tj
/TT0 1 Tf
0.021 Tw 5.9775 0 0 5.9775 424.437 449.1087 Tm
[(For)-20( )1(research)-16( )1(use)-25( )1(only.)-91( )1(CAUTION:)-13( )1(Not)-12( )1(for)-1( )1(human)-72( )1(or)]TJ
0 -1.333 TD
[(animal)-94( )1(therapeutic)-36( )1(or)-97( )1(diagnostic)-13( )1(use.)]TJ
ET
q
/GS0 gs
564.5375671 0 0 -0.6641693 15.3132935 706.8034821 cm
/Im1 Do
Q
BT
/TT0 1 Tf
0 Tw 10.6266 0 0 10.6266 21.2908 81.8272 Tm
( )Tj
ET
q
10 36 575 780 re
W n
/CS3 cs 0.302 0.306 0.333 scn
q 1 0 0 1 19.2983 691.5278 cm
0 0 m
0 1.771 -2.657 1.771 -2.657 0 c
-2.657 -1.771 0 -1.771 0 0 c
f
Q
Q
BT
/CS3 cs 0.302 0.306 0.333 scn
/TT1 1 Tf
-0.007 Tw 9.2983 0 0 9.2983 28.5965 688.8711 Tm
[(Rabbit)-50( Anti)-28(-)-69(CD31)-16( Polyclonal)-4( Antibody,)-47( Biotin)-37( conjugated)]TJ
/CS0 cs 0 scn
/TT0 1 Tf
0 Tw 10.6266 0 0 10.6266 25.2757 307.6422 Tm
( )Tj
ET
q
/GS0 gs
99.6242828 0 0 -75.050293 153.4589691 391.9907532 cm
/Im2 Do
Q
BT
/TT0 1 Tf
10.6266 0 0 10.6266 153.459 307.6422 Tm
( )Tj
ET
q
/GS0 gs
99.6242828 0 0 -75.050293 282.306366 391.9907532 cm
/Im3 Do
Q
BT
/TT0 1 Tf
10.6266 0 0 10.6266 282.3064 307.6422 Tm
( )Tj
-24.188 -2.25 Td
( )Tj
12.063 0 Td
( )Tj
12.125 0 Td
( )Tj
-24.188 -2.25 Td
( )Tj
12.063 0 Td
( )Tj
12.125 0 Td
( )Tj
-0.04 Tw 7.3058 0 0 7.3058 26.604 227.9428 Tm
[(For)-30( full)-30( size)-82( images)-63( and description)-26( please)-13( click)-31( )]TJ
/CS3 cs 0 0.6 0.8 scn
0 Tw 6.6416 0 0 6.6416 180.6896 227.9428 Tm
(HERE)Tj
/CS0 cs 0 scn
7.3058 0 0 7.3058 197.2936 227.9428 Tm
(.)Tj
ET
q
/GS0 gs
0.6641693 0 0 -597.7456512 410.4896088 706.1392975 cm
/Im4 Do
Q
q
/GS0 gs
5.9774628 0 0 -40.5138702 569.888443 120.3485565 cm
/Im5 Do
Q
endstream
endobj
14 0 obj
<>
endobj
15 0 obj
(\n͒MD/UT6:\r/)
endobj
26 0 obj
<>stream
Hy\E323#3
P̴,HLEK"+E+2VTD%EH# }wfwfvvc_3?{feޝ@HHHHHH*豘V]
zן)@-9.q2BÇEڂ8g "2vn>u2]/Yz \S@ 7.M&p?o9v 0'rKś-;(Au.J%% %&˶0>6`TxOzzo(VDY*AZp ËgAs^.㮌+2Ȱ$E['FC:OMCIVVDD3}`u߈buߨɴ4қԭV^V0XF ϓ@i|Y|.?i'3}Ŵ+ޘaa:
3g},F"kNɳՕx57,H)X7*v/Mո+(fWr=WӃJcߓtG16sPt:t"9G
if
3do\ˢ|c:1&<ЭWnPdq0IRgu~惘n9BWV2T6~}rs4h-D.sgV/n3;q@hThI*jTJqJK2c!QT7;60
5NoJݻ'rBP%ȍ4
P(/CJC1
9eڴ}5S{"wty@P5e*Zg~?S(Sɗ,ʽv 2[̋t_Z\d&}/2YϹO&y#
?P>,0P-
asds[U꼩\=T~)S>B,gk$7+j0?60<&uźg
A]_@en%Mȝ~5PSu$^2s0RSPw L9٦n9$vڣ=f#g 7,Oa
:ܾ.4+H!=MvF(G|YU
ITR)>@✧*[j5KoB{Kp,`姙$JO궒jvż@r3`w\A%jSx+>m;5ا@._1:T#q]wrTC8r:lU4P}~Y]XwJ~b:YQϗLP-X_ֻа2$ݥC=~P]VҘLhu?S'\C:7"4dD*%9 Ogfe\OLoTy5Qkj.84,: t:_YON3˃:O/r犁3t!Psbty{aETu7nMѶ f+^Y6zHic?R%+C,γL =ZJ1H+,x^
I!u2{5x_@LI6[w5LN5:xXoEgf9tu=yùw=aґza*҃K`驪eP/y*sσn3N{ME\8g: *fz#W??L